Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination. (Q38878763)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jack P. Antel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Anna Preisner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Stefanie Albrecht

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Qiao-Ling Cui

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Stephanie Hucke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Julia Ghelman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Makoto Mark Taketo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Luisa Klotz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Tanja Kuhlmann

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

6 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

published in

Acta Neuropathologica

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

247-261

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25943886%20AND%20SRC:MED&resulttype=core&format=json

Immune ablation followed by autologous hematopoietic stem cell transplantation for the treatment of poor prognosis multiple sclerosis

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

SRY-box containing gene 17 regulates the Wnt/β-catenin signaling pathway in oligodendrocyte progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Human fetal oligodendrocyte progenitor cells from different gestational stages exhibit substantially different potential to myelinate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Stage-specific regulation of oligodendrocyte development by Wnt/β-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

A regenerative approach to the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Extensive remyelination of the CNS leads to functional recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Biochemical and functional characterization of three activated macrophage populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Overcoming remyelination failure in multiple sclerosis and other myelin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Why does remyelination fail in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Neuroprotection and repair in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Remyelination capacity of the MS brain decreases with disease chronicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Synergistic effect of indomethacin and NGX6 on proliferation and invasion by human colorectal cancer cells through modulation of the Wnt/beta-catenin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Remyelination protects axons from demyelination-associated axon degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

In vitro and in vivo characterisation of glial cells immortalised with a temperature sensitive SV40 T antigen-containing retrovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

beta-catenin destruction complex: insights and questions from a structural perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

The complex world of oligodendroglial differentiation inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Late motor decline after accomplished remyelination: impact for progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

LINGO-1 negatively regulates myelination by oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Remyelination can be extensive in multiple sclerosis despite a long disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Remyelination is extensive in a subset of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Microglial recruitment, activation, and proliferation in response to primary demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Abrogation of β-catenin signaling in oligodendrocyte precursor cells reduces glial scarring and promotes axon regeneration after CNS injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

The many faces and functions of β-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Alternative Wnt pathways and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z

GSK3β negatively regulates oligodendrocyte differentiation and myelination in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1426-Z